Drawing for CONCATENO

USPTO serial 79063082

CONCATENO

Reviewed by CopyMark Law Group

Reg. 3860787Status 404
Filing date
Status date
Registration date
Oct 12, 2010
Examiner
MARTIN, LIEF ANDREW
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CONCATENO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry and science; chemical reagents for non-medical purposes, namely, diagnostic and immunodiagnostic reagents, for sale in kit form or individually; chemical preparations for non-medical scientific purposes, for sale in kit form or individuallySECTION 71 - CANCELLED—
005Diagnostic and immunodiagnostic reagents for medical purposes, for sale in kit form or individually; diagnostic and immunodiagnostic reagents for medical purposes, namely, preparations for testing for the presence of analytes in biological fluids or other matrices, for sale in kit form or individually; chemical preparations for medical purposes, namely, chemical reagents for medical use, for sale in kit form or individuallySECTION 71 - CANCELLED—
009Scientific, weighing, measuring, and checking apparatus and instruments, namely, testing sample collection and analysis equipment comprising, handheld electronic readers and analyzers for measuring, testing and analyzing bodily fluids, all the foregoing for scientific research use; systems for visual interpretation of test data, comprising wipes, swabs, microplates, collection cups and untreated test strips, namely, clinical laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; apparatus for carrying out diagnostic tests, namely, handheld electronic readers and analyzers for measuring, testing and analyzing bodily fluids, the foregoing for scientific research use; systems for visual interpretation of test data, comprising wipes, swabs, microplates, collection cups and untreated test strips, namely, clinical laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; on-site systems, namely, handheld electronic readers and analyzers for measuring, testing and analyzing bodily fluids, the foregoing for scientific research use; systems for visual interpretation of test data, for detection of drugs of abuse in powders, tablets, resins, liquids and on surfaces, comprising wipes, swabs, microplates, collection cups and untreated test strips, the foregoing for scientific research use; apparatus for use in non-destructive testing, namely, handheld electronic readers and analyzers for measuring, testing and analyzing bodily fluids, the foregoing for scientific research use; systems for visual interpretation of test data, comprising wipes, swabs, microplates, collection cups and untreated test strips, namely, clinical laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; apparatus, namely, handheld electronic readers and analyzers for measuring, testing and analyzing bodily fluids, the foregoing for scientific research use; systems comprising concentration meters, for visual interpretation of test data, for detection of drugs of abuse in powders, tablets, resins, liquids and on surfaces; testing apparatus, namely, handheld electronic readers and analyzers for measuring, testing and analyzing bodily fluids, the foregoing for scientific research use; systems comprising concentration meters, for visual interpretation of test data, for non-medical drug and alcohol testing services; non-medical diagnostic testing apparatus and instruments for use in immunoassay procedures, comprising wipes, swabs, microplates, collection cups and untreated test strips; non-medical testing apparatus, namely, handheld electronic readers and analyzers for measuring, testing and analyzing bodily fluids, the foregoing for scientific research purposes; systems for visual interpretation of immunoassay test data for sale in kit form, comprising wipes, swabs, microplates, collection cups and untreated test strips, the foregoing for scientific research purposes; monitoring and measuring apparatus, namely, handheld electronic readers and analyzers for measuring, testing and analyzing bodily fluids, the foregoing for scientific research purposes; systems for visual interpretation of test data, comprising wipes, swabs, microplates, collection cups and untreated test strips, for detection of drugs or alcohol, namely, clinical laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; apparatus, namely, handheld electronic readers and analyzers for measuring, testing and analyzing bodily fluids, the foregoing for scientific research purposes; systems comprising concentration meters, for visual interpretation of scientific research test data, for detection of drugs of abuse in powders, tablets, resins, liquids and on surfaces; apparatus and instruments, namely, handheld electronic readers and analyzers for measuring, testing and analyzing bodily fluids, the foregoing for scientific research purposes; systems comprising concentration meters, for visual interpretation of test data, for monitoring, measuring and testing for content of materials in the body and in bodily fluids, the foregoing for scientific research purposes; handheld electronic readers and analyzers for measuring, testing and analyzing bodily fluids, the foregoing for scientific research purposes; systems for visual interpretation of test data, for drug and alcohol testing services comprising wipes, swabs, microplates, collection cups and untreated test strips, the foregoing for scientific research purposes; alcohol detection and testing equipment, namely, alcohol test meters, namely, electronic apparatus for testing alcohol or drug content in blood, urine, oral fluids, saliva, breath, sweat, hair and forensic body materials, the foregoing for scientific research purposes; apparatus for testing blood, urine, oral fluids, saliva, breath, sweat, hair and forensic body materials for detection of alcohol, namely, handheld electronic readers and analyzers for measuring, testing and analyzing bodily fluids, the foregoing for scientific research purposes; systems for visual interpretation of drug concentration test data, comprising wipes, swabs, microplates, collection cups and untreated test strips, the foregoing for scientific research purposes; drug detection and testing equipment, namely, handheld electronic readers and analyzers for measuring, testing and analyzing bodily fluids, the foregoing for scientific research purposes; systems for visual interpretation of drug concentration test data, comprising wipes, swabs, microplates, collection cups and untreated test strips, the foregoing for scientific research purposes; alcohol meters, namely, electronic meters for testing alcohol or drug content in blood, urine, oral fluids, saliva, breath, sweat, hair and forensic body materials, the foregoing for scientific research purposes; computer software for collecting, storing, reviewing and analyzing scientific test data; computer software for linking laboratory services with remote sites to enable storage and reporting of specimen resultsSECTION 71 - CANCELLED—
010Medical apparatus, namely, oral fluid collection devices for testing of blood, urine, oral fluids, saliva, breath, sweat, hair and forensic body materials, for detection of drugs or alcohol; diagnostic and immunodiagnostic apparatus for medical purposes, namely, reagent delivery devices and instruments in the nature of immunodiagnostic kits comprising wipes, swabs microplates, collection cups and untreated test strips, sold empty, for testing of blood, urine, oral fluids, saliva, breath, hair and forensic body materials, for detection of drugs or alcohol; medical kits comprising apparatus for testing the presence of analytes in biological fluids, other fluids and other matrices; medical reagent delivery devices, in the nature of capillary reagent tubes; reagent delivery devices, for testing the presence of analytes in biological fluids, other fluids and other matrices, namely, capillary reagent tubes; component parts for all the aforementioned goodsSECTION 71 - CANCELLED—
042Biochemical, toxicological and other analytical non-medical laboratory diagnostic testing services, namely, analytical laboratory testing services for the detection of the presence of analytes in biological fluids, other fluids and other matrices, evaluation and testing of illegal drug laboratory sites for the presence of hazardous and illegal materials, testing for detection of drugs of abuse in powders, tablets, resins, liquids and on surfaces; design and development of medical diagnostic testing apparatus and reagents; laboratory testing services, namely, services for testing for the presence of analytes in biological fluids, other fluids and other matrices, for forensic research purposes; evaluation and testing of illegal drug laboratory sites for the presence of hazardous and illegal materials, testing for detection of drugs of abuse in powders, tablets, resins, liquids and on surfaces; analysis and testing of physiological samples, namely, analysis and testing for the presence of analytes in biological fluids, other fluids and other matrices, for forensic research purposes; scientific research services relating to immunodiagnostic testing, including testing for the presence of drugs or other analytes in biological fluids, other fluids and other matrices; testing services for content of materials in the body and in bodily fluids, namely, services for testing for the presence of analytes in biological fluids, other fluids and other matrices, for forensic research purposes; alcohol, drug, solvent and disease testing and screening services, namely, services for testing for the presence of analytes in biological fluids, other fluids and other matrices, for forensic research purposes; scientific and technological services, namely, laboratory testing for the presence of analytes in biological fluids, other fluids and other matrices relating to detection and investigation of the use of drugs, solvents and alcohol by analysis of hair, nail or body fluids, for forensic research purposes; drug, solvent and alcohol use analysis, namely, drug, solvent and alcohol screening services for forensic research purposes; consultancy in the field of drug, solvent and alcohol screening for forensic research purposes; rental of integrated drug, solvent and alcohol testing products in the nature of drug and alcohol testing kits for forensic research purposes; rental of equipment for testing and analysis and for alcohol, solvent and drug detection services, namely, rental of drug and alcohol testing kits for forensic research purposes; scientific research services; information, advisory and consultancy services relating to all the aforesaid servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 14, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Dec 14, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
May 25, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 23, 2018INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jan 29, 2018INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jan 29, 2018INPCINVALIDATION PROCESSED—
Jan 19, 2018INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 21, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 19, 2017C71TCANCELLED SECTION 71—
Jan 26, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 12, 2015REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 17, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 6, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 13, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 13, 2011FIMPFINAL DISPOSITION PROCESSED—
Jan 12, 2011FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 12, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 27, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 27, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 24, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 22, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 22, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Jun 22, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 22, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 22, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 21, 2010JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jun 18, 2010OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 4, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 4, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 4, 2010ALIEASSIGNED TO LIE—
Jun 3, 2010OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 3, 2010OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 25, 2010EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 29, 2010GEA1NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED—
Mar 29, 2010GECDACTION DENYING REQ FOR RECON E-MAILED—
Mar 29, 2010CNCFACTION CONTINUING FINAL - COMPLETED—
Feb 25, 2010EXPIEX PARTE APPEAL-INSTITUTED—
Feb 25, 2010JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Feb 25, 2010EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Feb 25, 2010ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 25, 2009GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 25, 2009GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 25, 2009CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 25, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 25, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 19, 2009PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Aug 7, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 7, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 7, 2009ALIEASSIGNED TO LIE—
Jul 22, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 22, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 13, 2009RFNTREFUSAL PROCESSED BY IB—
Jan 22, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 22, 2009RFRRREFUSAL PROCESSED BY MPU—
Jan 22, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 21, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 15, 2009DOCKASSIGNED TO EXAMINER—
Jan 13, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 7, 2009DOCKASSIGNED TO EXAMINER—
Jan 7, 2009NWAPNEW APPLICATION ENTERED—
Jan 6, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance